BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Brainsway Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 20, 2026
$11.99+0.55 (+4.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 66.6
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
11M
Shares held, 13F filers
Institutional holders
56
8 new, 8 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 7 sales
Net bought $0
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jonathan Shulkin | 5,851,444 | 15.00% | 13D (active) amendment | Oct 6, 2025 |
| Harel Insurance Investments & Financial Services Ltd. | 3,265,397 | 8.30% | 13G (passive) amendment | Jun 30, 2026 |
| Meitav Investment House Ltd | 2,532,352 | 6.31% | 13G (passive) amendment | Jun 1, 2026 |
| Harel Insurance Investments & Financial Services Ltd | 1,981,714 | 5.20% | 13G (passive) | Feb 16, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BWAY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Valor Management LLC | 5,314,950 | – | $82.43M | – | 0.10% |
| Masters Capital Management LLC | 1,500,000 | – | $23.27M | −150,000 | 0.60% |
| Acadian Asset Management LLC | 807,931 | – | $12.51K | −10,341 | 0.01% |
| Essex Investment Management Co LLC | 592,606 | – | $9.19M | −25,947 | 1.20% |
| Renaissance Technologies LLC | 475,920 | – | $7.38M | −42,500 | 0.01% |
| Cresset Asset Management, LLC | 314,924 | – | $4.88M | – | 0.02% |
| Y.D. More Investments Ltd | 237,433 | – | $3.68M | −34,571 | 0.11% |
| Legato Capital Management LLC | 197,635 | – | $3.07M | +5,485 | 0.25% |
| Morgan Stanley | 188,968 | – | $2.93M | +84,574 | 0.00% |
| Eagle Global Advisors LLC | 182,606 | – | $2.83M | +10,000 | 0.09% |
| ARK Investment Management LLC | 142,500 | – | $2.21M | −51,186 | 0.01% |
| Sei Investments Co | 119,717 | – | $1.86M | −106,661 | 0.00% |
| UBS Group AG | 101,077 | – | $1.57M | +18,935 | 0.00% |
| Sigma Planning Corp | 100,435 | – | $1.56M | +30,072 | 0.04% |
| Two Sigma Investments, LP | 99,545 | – | $1.54M | −28,642 | 0.00% |
| Royce & Associates LP | 97,033 | – | $1.50M | – | 0.01% |
| JPMorgan Chase & Co | 96,807 | – | $1.47M | +49,777 | 0.00% |
| Goldman Sachs Group Inc | 92,091 | – | $1.43M | −15,621 | 0.00% |
| Toroso Investments, LLC | 89,248 | – | $1.38M | +74,193 | 0.00% |
| Huntleigh Advisors, Inc. | 87,306 | – | $1.35M | +5,787 | 0.19% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | 11M | 8 / 15 | 19 / 8 | 0M | 1M |
| Q1 2026 | 56 | 12M | 21 / 32 | 3 / 8 | 6M | 0M |
| Q4 2025 | 43 | 6M | 7 / 16 | 13 / 8 | 1M | 1M |
| Q3 2025 | 44 | 6M | 10 / 17 | 8 / 7 | 0M | 1M |
| Q2 2025 | 42 | 6M | 5 / 11 | 19 / 5 | 0M | 0M |
| Q1 2025 | 42 | 6M | 9 / 11 | 12 / 6 | 0M | 0M |
| Q4 2024 | 39 | 6M | 11 / 12 | 14 / 4 | 3M | 0M |
| Q3 2024 | 32 | 3M | 7 / 14 | 5 / 2 | 0M | 1M |
| Q2 2024 | 27 | 4M | 5 / 5 | 12 / 7 | 0M | 1M |
| Q1 2024 | 29 | 4M | 8 / 10 | 7 / 6 | 1M | 1M |
| Q4 2023 | 27 | 4M | 12 / 6 | 7 / 0 | 1M | 1M |
| Q3 2023 | 15 | 5M | 2 / 7 | 2 / 3 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BWAY | Value | % of fund | As of |
|---|---|---|---|---|---|
| Timothy Plan Israel Common Values Fund | 182,606 | – | $2.83M | 1.38% | Jun 30, 2026 |
| ARK Israel Innovative Technology ETF | 146,850 | – | $2.24M | 1.63% | Jul 31, 2026 |
| 1290 Essex Small Cap Growth Fund | 138,592 | – | $2.11M | 1.82% | Jul 31, 2026 |
| Royce Smaller-Companies Growth Fund | 97,000 | – | $1.50M | 0.63% | Jun 30, 2026 |
| Amplify BlueStar Israel Technology ETF | 74,453 | – | $1.15M | 0.96% | Jun 30, 2026 |
| Steward Values Enhanced International Fund | 25,351 | – | $386.10K | 0.11% | Jul 31, 2026 |
| ActivePassive International Equity ETF | 19,005 | – | $301.99K | 0.03% | May 31, 2026 |
| Even Herd Long Short ETF | 14,795 | – | $229.47K | 0.38% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 13,705 | – | $217.77K | 0.00% | May 31, 2026 |
| Voya Multi-Manager International Small Cap Fund | 9,834 | – | $149.77K | 0.03% | Jul 31, 2026 |
| Defiance Autism Impact ETF | 2,250 | – | $34.90K | 2.58% | Jun 30, 2026 |
| iShares Neuroscience and Healthcare ETF | 1,724 | – | $26.26K | 0.48% | Jul 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 800 | – | $12.41K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Gilad Moiseyev | Chief Technology Officer | 53,098 | Jun 22, 2026 |
| Yiftach Roth | Chief Scientist | 1,074,305 | Jun 3, 2026 |
| Colleen Hanlon | VP of Medical Affairs | 53,881 | Mar 18, 2026 |
| Hadar Levy | Chief Executive Officer | 123,050 | Mar 18, 2026 |
| Ido Marom | Chief Financial Officer | 51,250 | Mar 18, 2026 |
| Naomi Rozenfeld | Chief Marketing Officer | 25,000 | Mar 18, 2026 |
| Rayten Michal Ety Mitrany | Director | 12,500 | May 26, 2026 |
| Jonathan K. Shulkin | Director | 5,851,444 | Mar 18, 2026 |
| David Zacut | Director | 1,791,468 | Mar 18, 2026 |
| Karen Sarid | Director | 12,500 | Mar 18, 2026 |
| Amiram Boehm | Director | 18,750 | Mar 18, 2026 |
| Abraham Zangen | Director | 905,963 | Mar 18, 2026 |
| Avner Lushi | Director | 6,250 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gilad Moiseyev Chief Technology Officer | Jun 15, 2026 | Sale | −5,000 | – | – | 53,098 |
| Yiftach Roth Chief Scientist | Jun 2, 2026 | Sale | −1,000 | – | – | 1,074,305 |
| Yiftach Roth Chief Scientist | Jun 2, 2026 | Sale | −2,000 | – | – | 1,072,305 |
| Yiftach Roth Chief Scientist | Jun 1, 2026 | Sale | −2,000 | – | – | 1,077,305 |
| Yiftach Roth Chief Scientist | Jun 1, 2026 | Sale | −2,000 | – | – | 1,075,305 |
| Rayten Michal Ety Mitrany Director | May 26, 2026 | Sale | −7,980 | – | – | 12,500 |
| Gilad Moiseyev Chief Technology Officer | May 25, 2026 | Option exercise | +7,500 | – | – | 60,000 |
| Gilad Moiseyev Chief Technology Officer | May 25, 2026 | Tax withholding | −1,902 | – | – | 58,098 |
| Rayten Michal Ety Mitrany Director | May 25, 2026 | Sale | −10,000 | – | – | 20,480 |
| Rayten Michal Ety Mitrany Director | May 20, 2026 | Option exercise | +17,500 | – | – | 36,560 |
| Rayten Michal Ety Mitrany Director | May 20, 2026 | Tax withholding | −6,080 | – | – | 30,480 |
| Rayten Michal Ety Mitrany Director | May 19, 2026 | Option exercise | +10,000 | – | – | 22,500 |
| Rayten Michal Ety Mitrany Director | May 19, 2026 | Tax withholding | −3,440 | – | – | 19,060 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.